Chinese Pharmaceuticals & Biotech Best Growth Stocks

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥13.1b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Xiamen Amoytop Biotech

Market Cap: CN¥34.1b

Engages in research, development, production, and sale of recombinant protein drugs in China.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.3b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Boji Medical TechnologyLtd

Market Cap: CN¥3.8b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥32.6b

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.5b

Shanghai Rightongene Biotechnology Co., Ltd.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥16.8b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Beijing Sun-Novo Pharmaceutical Research

Market Cap: CN¥7.3b

A contract research company, engages in the research and development of drugs in China.